|
FIRMS HAVE MIXED REACTIONS ON ANTIDEPRESSANT VOTE
GlaxoSmithKline (GSK), maker of the antidepressant Paxil (paroxetine), praised the joint FDA panel’s recommendation last week that drew a link between antidepressant use and the risk of suicidal behavior in children and adolescents who take the products. This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives